Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by MementoMorion Feb 07, 2012 1:20pm
359 Views
Post# 19500358

RE: My Little Bit

RE: My Little Bit

> The website does tell me that 11 drugs in this class are undergoing Phase 2 trials

> and 4 are undergoing Phase 3 trials. Is voclosporin in one of these trials or

> have Isotechnika and Paladin dismissed this opportunity despite the

> dermatologists positive outlook.

Paladin & Isotechnika submitted Voclosporin (Voclera) for Canadian marketing approval for psoriasis on December 20, 2010. There has been no response yet; it takes on average 18 months for a decision, which puts us into June.

<< Previous
Bullboard Posts
Next >>